Development of sputum calprotectin as a biomarker of cystic fibrosis lung disease activity: Evidence from cross sectional and longitudinal studies

R. D. Gray, M. Imrie, A. C. Boyd, J. A. Innes, D. Porteous, A. P. Greening

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)II34-II35
Publication statusPublished - 2006

Cite this